CORE LABORATORIES INC (CLB)

US21867A1051 - Common Stock

16.99  +0.3 (+1.8%)

After market: 16.99 0 (0%)

Fundamental Rating

4

CLB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 65 industry peers in the Energy Equipment & Services industry. CLB has an average financial health and profitability rating. CLB is valied quite expensively at the moment, while it does show a decent growth rate.



5

1. Profitability

1.1 Basic Checks

CLB had positive earnings in the past year.
In the past year CLB had a positive cash flow from operations.
CLB had positive earnings in 4 of the past 5 years.
CLB had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.26%, CLB is in the better half of the industry, outperforming 66.15% of the companies in the same industry.
Looking at the Return On Equity, with a value of 16.32%, CLB is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
CLB's Return On Invested Capital of 8.97% is fine compared to the rest of the industry. CLB outperforms 63.08% of its industry peers.
CLB had an Average Return On Invested Capital over the past 3 years of 7.69%. This is in line with the industry average of 8.59%.
The last Return On Invested Capital (8.97%) for CLB is above the 3 year average (7.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.26%
ROE 16.32%
ROIC 8.97%
ROA(3y)4.34%
ROA(5y)1.8%
ROE(3y)13.16%
ROE(5y)-7.94%
ROIC(3y)7.69%
ROIC(5y)8.82%

1.3 Margins

CLB has a better Profit Margin (7.20%) than 63.08% of its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
Looking at the Operating Margin, with a value of 11.27%, CLB is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
In the last couple of years the Operating Margin of CLB has declined.
CLB has a worse Gross Margin (21.54%) than 61.54% of its industry peers.
CLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.27%
PM (TTM) 7.2%
GM 21.54%
OM growth 3Y-2.8%
OM growth 5Y-8.16%
PM growth 3YN/A
PM growth 5Y-8.71%
GM growth 3Y-2.28%
GM growth 5Y-5.83%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
The number of shares outstanding for CLB has been increased compared to 1 year ago.
Compared to 5 years ago, CLB has more shares outstanding
Compared to 1 year ago, CLB has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.06 indicates that CLB is not in any danger for bankruptcy at the moment.
CLB's Altman-Z score of 3.06 is fine compared to the rest of the industry. CLB outperforms 72.31% of its industry peers.
The Debt to FCF ratio of CLB is 11.48, which is on the high side as it means it would take CLB, 11.48 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 11.48, CLB is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.73 indicates that CLB is somewhat dependend on debt financing.
CLB has a worse Debt to Equity ratio (0.73) than 66.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 11.48
Altman-Z 3.06
ROIC/WACC1.05
WACC8.53%

2.3 Liquidity

A Current Ratio of 2.53 indicates that CLB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.53, CLB is in the better half of the industry, outperforming 70.77% of the companies in the same industry.
A Quick Ratio of 1.72 indicates that CLB should not have too much problems paying its short term obligations.
CLB has a Quick ratio of 1.72. This is in the better half of the industry: CLB outperforms 70.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 1.72

4

3. Growth

3.1 Past

CLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.66%, which is quite impressive.
The earnings per share for CLB have been decreasing by -18.70% on average. This is quite bad
Looking at the last year, CLB shows a small growth in Revenue. The Revenue has grown by 4.09% in the last year.
CLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.17% yearly.
EPS 1Y (TTM)39.66%
EPS 3Y0.84%
EPS 5Y-18.7%
EPS growth Q2Q-5%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y1.52%
Revenue growth 5Y-6.17%
Revenue growth Q2Q0.48%

3.2 Future

CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.81% yearly.
CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.87% yearly.
EPS Next Y54.35%
EPS Next 2Y42.07%
EPS Next 3Y25.76%
EPS Next 5Y19.81%
Revenue Next Year8.83%
Revenue Next 2Y6.82%
Revenue Next 3Y3.69%
Revenue Next 5Y3.87%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.98, the valuation of CLB can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as CLB.
Compared to an average S&P500 Price/Earnings ratio of 24.80, CLB is valued at the same level.
A Price/Forward Earnings ratio of 13.59 indicates a correct valuation of CLB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLB is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CLB to the average of the S&P500 Index (21.27), we can say CLB is valued slightly cheaper.
Industry RankSector Rank
PE 20.98
Fwd PE 13.59

4.2 Price Multiples

80.00% of the companies in the same industry are cheaper than CLB, based on the Enterprise Value to EBITDA ratio.
CLB's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CLB is more expensive than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 56.03
EV/EBITDA 12.7

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLB's earnings are expected to grow with 25.76% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y42.07%
EPS Next 3Y25.76%

3

5. Dividend

5.1 Amount

CLB has a yearly dividend return of 0.22%, which is pretty low.
Compared to an average industry Dividend Yield of 2.54, CLB pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.22, CLB pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.22%

5.2 History

The dividend of CLB decreases each year by -73.70%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-73.7%
Div Incr Years0
Div Non Decr Years2

5.3 Sustainability

5.09% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.09%
EPS Next 2Y42.07%
EPS Next 3Y25.76%

CORE LABORATORIES INC

NYSE:CLB (4/18/2024, 7:04:00 PM)

After market: 16.99 0 (0%)

16.99

+0.3 (+1.8%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap796.15M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.22%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.98
Fwd PE 13.59
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.26%
ROE 16.32%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.27%
PM (TTM) 7.2%
GM 21.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.53
Quick Ratio 1.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)39.66%
EPS 3Y0.84%
EPS 5Y
EPS growth Q2Q
EPS Next Y54.35%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.09%
Revenue growth 3Y1.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y